Trial Search Results

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial.

Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

The University of Texas Health Science Center, Houston

Collaborator: Lucile Packard Children's Hospital

Stanford Investigator(s):

Intervention(s):

  • Other: phototherapy

Phase:

N/A

Eligibility


Inclusion Criteria:

   - birth weight 401-1000 grams

   - age less than or equal to 24 hours

Exclusion Criteria:

   - hemolytic disease

   - major anomaly

   - overt nonbacterial infection

Ages Eligible for Study

N/A - 24 Hours

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
David K Stevenson, MD
497-0735
Recruiting